发明授权
US08536332B2 Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines
失效
用取代的吡啶并[2,3-b]吡嗪调节信号转导通路
![Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines](/docs/US/2013-09-17/US08536332B2/abs.jpg.600x600.jpg)
- 专利标题： Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines
- 专利标题（中）： 用取代的吡啶并[2,3-b]吡嗪调节信号转导通路
-
申请号： US13455187申请日： 2012-04-25
-
公开(公告)号： US08536332B2公开(公告)日： 2013-09-17
- 发明人: Matthias Gerlach , Irene Seipelt , Eckhard Guenther , Emmanuel Polymeropoulos , Tilmann Schuster , Eckhard Claus
- 申请人： Matthias Gerlach , Irene Seipelt , Eckhard Guenther , Emmanuel Polymeropoulos , Tilmann Schuster , Eckhard Claus
- 申请人地址： DE Frankfurt am Main
- 专利权人： Aeterna Zentaris GmbH
- 当前专利权人： Aeterna Zentaris GmbH
- 当前专利权人地址： DE Frankfurt am Main
- 代理机构： Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- 优先权： EP07107976 20070510
- 主分类号： C07D471/00
- IPC分类号： C07D471/00
![Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines](/abs-image/US/2013/09/17/US08536332B2/abs.jpg.150x150.jpg)
摘要：
Method of modulating ras-Raf-Mek-Erk signal transduction pathway, PI3K-Akt signal transduction pathway and/or SAPK signal transduction pathway with a pyrido[2,3-b]pyrazine of formula (Ia).
公开/授权文献
信息查询
